Jacintha N O'Sullivan

This paper develops patient-derived lung cancer organoids that replicate histological features of keratinizing squamous cell carcinoma, offering a tool for studying tumor biology and drug testing.

This study combines radiotherapy and NK cell immunotherapy to exploit an evolutionary double-bind strategy in prostate cancer, showing that RT-resistant cells become more vulnerable to NK cell killing.